Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
key study
Study period:
19 June 2020 to
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2020

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Deviations:
no
GLP compliance:
yes
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Reference substance name:
Saccharomyces cerevisiae cell wall, extracted
EC Number:
949-711-6
Molecular formula:
Not applicable (UVCB substance)
IUPAC Name:
Saccharomyces cerevisiae cell wall, extracted
Test material form:
solid: particulate/powder
Specific details on test material used for the study:
SOURCE OF TEST MATERIAL
- Batch number of test material: AD19K01750
- Expiration date of the lot/batch: 27 July 2021

Method

Species / strain
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
Metabolic activation:
with and without
Metabolic activation system:
Type and composition of metabolic activation system:
- source of S9 : Rat (Wistar) Liver Homogenate
- method of preparation of S9 mix : Rats treated with phenobarbital (PB) and -naphthoflavone (BNF) at 80 mg/kg/day by oral gavage for three consecutive days. On day 4, washed livers were transferred to a beaker containing 3 mL of 0.15 M KCl per g of wet liver, and homogenized. Homogenates were centrifuged for 10 min at 9000 g and the supernatant was decanted and retained.
- Volume of S9 mix in the final culture medium: 500 µL
Test concentrations with justification for top dose:
500, 158.1, 50, 15.81, 5, 1.581, 0.5 and 0.1581 μg/plate, for all strains and with/without activation.
Precipitation and cytotoxicity observed down to 158.1 µg/plate with and without activation.
Cytox
Vehicle / solvent:
- Vehicle used: Distilled water
- Justification for choice of vehicle: Suitable homogenous light beige suspension obtained with distilled water, not with neither DMSO nor DMF.
Controls
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
9-aminoacridine
sodium azide
other: 4-nitro-1,2-phenylene-diamine (NPD) Without S9 - Salmonella TA98 Methyl-methanesulfonate (MMS) Without S9 - E.coli WP2 uvrA 2-aminoanthracene (2AA) With S9 - All Salmonella strains and E.coli WP2 uvrA
Details on test system and experimental conditions:
NUMBER OF REPLICATIONS:
- Number of cultures per concentration: triplicates
- Number of independent experiments: 2

METHOD OF TREATMENT/ EXPOSURE:
- Cell density at seeding: Ranging from 1.39 x10-9 CFU/mL to 3.2x10-9 CFU/mL.
- Test substance added in medium:
* Assay 1: Direct incorporation then in agar plate.
* Assay 2 (all strains except S. TA1535)/3 (S. TA1535 only): Preincupation then in agar plate.

TREATMENT AND HARVEST SCHEDULE:
- Preincubation period: Assay 2 (all strains except S. TA1535)/3 (S. TA1535 only): 20 minutes at 37°C.
- Exposure duration/duration of treatment: 48h at 37°C
- Harvest time after the end of treatment : at the end of the treatment period.

METHODS FOR MEASUREMENT OF CYTOTOXICITY
- Method: reduced/slight reduced background lawn development
Evaluation criteria:
A test item is considered mutagenic if:
* a concentration-related increase in the number of revertants occurs and/or;
* a reproducible biologically relevant positive response for at least one of the dose groups occurs in at least one strain with or without metabolic activation.
An increase is considered biologically relevant if:
* the number of reversions is more than two times higher than the reversion rate of the negative (solvent) control in Salmonella typhimurium TA98, TA100 and Escherichia coli WP2 uvrA bacterial strains;
* the number of reversions is more than three times higher than the reversion rate of the negative (solvent) control in Salmonella typhimurium TA1535 and TA1537 bacterial strains.
According to the guidelines, statistical method may be used as an aid in evaluating the test results. However, statistical significance should not be the only determining factor for a positive response

Results and discussion

Test resultsopen allclose all
Key result
Species / strain:
S. typhimurium TA 1535
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
other: tested up to cytotoxicity/precipitating concentrations (500 µg/plate)
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
True negative controls validity:
not applicable
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 1537
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
other: tested up to cytotoxicity/precipitating concentrations (500 µg/plate)
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
True negative controls validity:
not applicable
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 98
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
other: tested up to cytotoxicity/precipitating concentrations (500 µg/plate)
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
True negative controls validity:
not applicable
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
other: tested up to cytotoxicity/precipitating concentrations (500 µg/plate)
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
True negative controls validity:
not applicable
Positive controls validity:
valid
Key result
Species / strain:
E. coli WP2 uvr A
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
other: tested up to cytotoxicity/precipitating concentrations (500 µg/plate)
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
True negative controls validity:
not applicable
Positive controls validity:
valid

Any other information on results incl. tables

Table1:Summary Table of the Assay 1

Concentrations

(mg /plate)

Mean values ofrevertants/ Mutation factor (MF)

Salmonella typhimuriumtester strains

Escherichia coli

TA98

TA100

TA1535

TA1537

WP2uvrA

-S9

+S9

-S9

+S9

-S9

+S9

-S9

+S9

-S9

+S9

Untreated control

Mean

18.0

20.3

86.7

95.3

16.3

16.0

12.0

12.0

44.0

44.7

MF

1.04

0.87

1.10

0.91

1.02

0.94

1.06

1.03

1.06

1.01

DMSO control

Mean

18.3

21.3

--

94.7

--

15.7

11.3

11.3

--

46.0

MF

1.06

0.91

--

0.90

--

0.92

1.00

0.97

--

1.04

Distilled water control

Mean

17.3

23.3

79.0

105.3

16.0

17.0

11.3

11.7

41.7

44.3

MF

1.00

1.00

1.00

1.00

1.00

1.00

1.00

1.00

1.00

1.00

500 R/P

Mean

16.0

20.7

89.3

95.7

16.3

16.3

11.3

11.7

45.3

43.0

MF

0.92

0.89

1.13

0.91

1.02

0.96

1.00

1.00

1.09

0.97

158.1 SR/P

Mean

15.7

21.0

100.0

111.7

15.3

16.0

10.3

10.7

45.7

46.7

MF

0.90

0.90

1.27

1.06

0.96

0.94

0.91

0.91

1.10

1.05

50

Mean

18.3

19.7

88.3

114.3

17.0

15.7

11.3

10.7

44.0

42.3

MF

1.06

0.84

1.12

1.09

1.06

0.92

1.00

0.91

1.06

0.95

15.81

Mean

17.3

21.0

89.3

115.0

16.7

16.7

8.7

10.0

43.7

44.7

MF

1.00

0.90

1.13

1.09

1.04

0.98

0.76

0.86

1.05

1.01

5

Mean

14.3

21.0

98.0

107.7

16.3

15.3

9.3

11.0

41.7

42.7

MF

0.83

0.90

1.24

1.02

1.02

0.90

0.82

0.94

1.00

0.96

1.581

Mean

14.7

20.0

101.0

112.0

16.3

15.7

10.7

11.3

41.0

45.7

MF

0.85

0.86

1.28

1.06

1.02

0.92

0.94

0.97

0.98

1.03

0.5

Mean

17.3

19.0

102.0

105.7

16.7

16.0

10.7

10.7

43.3

45.7

MF

1.00

0.81

1.29

1.00

1.04

0.94

0.94

0.91

1.04

1.03

0.1581

Mean

17.7

19.0

90.3

101.7

16.3

15.0

9.7

11.0

43.3

46.0

MF

1.02

0.81

1.14

0.97

1.02

0.88

0.85

0.94

1.04

1.04

NPD (4mg)

Mean

417.3

--

--

--

--

--

--

--

--

--

MF

22.76

--

--

--

--

--

--

--

--

--

2AA (2mg)

Mean

--

2469.3

--

2468.0

--

219.0

--

210.3

--

--

MF

--

115.75

--

26.07

--

13.98

--

18.56

--

--

2AA (50mg)

Mean

--

--

--

--

--

--

--

--

--

238.0

MF

--

--

--

--

--

--

--

--

--

5.17

SAZ (2mg)

Mean

--

--

1060.0

--

1217.3

--

--

--

--

--

MF

--

--

13.42

--

76.08

--

--

--

--

--

9AA (50mg)

Mean

--

--

--

--

--

--

412.0

--

--

--

MF

--

--

--

--

--

--

36.35

--

--

--

MMS (2mL)

Mean

--

--

--

--

--

--

--

--

1085.3

--

MF

--

--

--

--

--

--

--

--

26.05

--

 

Table2:Summary Table of the Assay 2 and Assay 3

Concentrations

(mg/plate)

Mean values ofrevertants/ Mutation factor (MF)

Salmonella typhimuriumtester strains

Escherichia coli

TA98

TA100

TA1535*

TA1537

WP2uvrA

-S9

+S9

-S9

+S9

-S9

+S9

-S9

+S9

-S9

+S9

 

Untreated control

Mean

16.0

19.0

91.0

103.3

17.0

16.3

8.0

11.0

44.3

48.3

 

MF

0.91

0.93

1.09

0.97

1.00

1.09

1.00

1.22

0.94

0.95

 

DMSO control

Mean

17.0

18.7

--

101.7

--

17.3

7.7

9.0

--

51.0

 

MF

0.96

0.92

--

0.95

--

1.16

0.96

1.00

--

1.00

 

Distilled water control

Mean

17.7

20.3

83.7

106.7

17.0

15.0

8.0

9.0

47.3

51.0

 

MF

1.00

1.00

1.00

1.00

1.00

1.00

1.00

1.00

1.00

1.00

 

500 R/P

Mean

17.3

18.3

40.7

96.7

15.0

11.3

6.0

6.7

49.0

49.7

 

MF

0.98

0.90

0.49

0.91

0.88

0.76

0.75

0.74

1.04

0.97

 

158.1 SR/P

Mean

17.7

19.0

61.0

109.0

16.0

16.7

3.3

5.7

50.0

51.3

 

MF

1.00

0.93

0.73

1.02

0.94

1.11

0.42

0.63

1.06

1.01

 

50

Mean

16.0

17.3

84.3

103.0

14.0

15.0

7.3

7.3

48.7

51.7

 

MF

0.91

0.85

1.01

0.97

0.82

1.00

0.92

0.81

1.03

1.01

 

15.81

Mean

17.0

17.7

94.0

100.0

15.0

15.0

7.7

8.7

48.0

52.7

 

MF

0.96

0.87

1.12

0.94

0.88

1.00

0.96

0.96

1.01

1.03

 

5

Mean

17.7

18.3

85.0

92.0

14.7

16.0

9.3

9.0

42.7

46.3

 

MF

1.00

0.90

1.02

0.86

0.86

1.07

1.17

1.00

0.90

0.91

 

1.581

Mean

17.0

18.7

78.0

91.0

15.3

14.3

8.7

8.7

48.0

51.0

 

MF

0.96

0.92

0.93

0.85

0.90

0.96

1.08

0.96

1.01

1.00

 

0.5

Mean

16.3

18.3

80.7

111.3

14.3

14.0

8.3

8.3

48.0

49.0

 

MF

0.92

0.90

0.96

1.04

0.84

0.93

1.04

0.93

1.01

0.96

 

0.1581

Mean

17.0

18.3

85.7

94.0

16.0

15.0

7.7

9.7

45.3

51.0

 

MF

0.96

0.90

1.02

0.88

0.94

1.00

0.96

1.07

0.96

1.00

 

NPD (4mg)

Mean

417.3

--

--

--

--

--

--

--

--

--

 

MF

24.55

--

--

--

--

--

--

--

--

--

 

2AA (2mg)

Mean

--

2421.3

--

2466.7

--

208.0

--

205.0

--

--

 

MF

--

129.71

--

24.26

--

12.00

--

22.78

--

--

 

2AA (50mg)

Mean

--

--

--

--

--

--

--

--

--

206.7

 

MF

--

--

--

--

--

--

--

--

--

4.05

 

SAZ (2mg)

Mean

--

--

1057.3

--

1176.0

--

--

--

--

--

 

MF

--

--

12.64

--

69.18

--

--

--

--

--

 

9AA (50mg)

Mean

--

--

--

--

--

--

441.3

--

--

--

 

MF

--

--

--

--

--

--

57.57

--

--

--

 

MMS (2mL)

Mean

--

--

--

--

--

--

--

--

1024.0

--

 

MF

--

--

--

--

--

--

--

--

21.63

--

 

*Assay3

 

P:           Precipitate                                                        

R:           Reduced background lawn development

SR:        Slightly reduced background lawn development

MF:       Mutation factor

SD:        Standard deviation

+S9:      with S9 mix

-S9:       withoutS9 mix

Applicant's summary and conclusion

Conclusions:
The reported data of this mutagenicity assay show that under the experimental conditions applied the test item did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used. In conclusion, the test item Saccharomyces cerevisiae cell wall, extractedhad no mutagenic activity on the growth of the bacterial strains under the test conditions used in this study.
Executive summary:

The test item was tested for potential mutagenic activity using the Bacterial Reverse Mutation Assay. The experiments were carried out using histidine-requiring auxotroph strains of Salmonella typhimurium (Salmonella typhimuriumTA98, TA100, TA1535 and TA1537) and the tryptophan-requiring auxotroph strain of Escherichia coli (Escherichia coliWP2uvrA) in the presence and absence of a post mitochondrial supernatant (S9 fraction) prepared from the livers of phenobarbital/b-naphthoflavone-induced rats.

The study included a Preliminary Compatibility Test, a Preliminary Concentration Range Finding Test, an Assay 1 (Plate Incorporation Method), an Assay 2 (Pre-Incubation Method) and an Assay 3 (Pre-Incubation Method). The performed Assay 2 in case of Salmonella typhimuriumTA1535 strain with and without metabolic activation could not be properly evaluated due to the observed contamination on the plates. Therefore, the performed Assay 2 in case of this strain was declared invalid and was repeated in an additional experiment (Assay 3) with and without metabolic activation with the same experimental conditions as in Assay 2. Based on the results of the preliminary experiment, the examined test concentrations in the assays were 500, 158.1, 50, 15.81, 5, 1.581, 0.5 and 0.1581μg/plate.

In the assays the number of revertant colonies did not show any biologically relevant increase compared to the solvent controls. There were no reproducible dose-related trends and there was no indication of any treatment-related effect. Precipitate was detected on the plates in the main tests in all examined bacterial strains with and without metabolic activation at higher concentrations. Inhibitory, cytotoxic effect of the test item on the lawn growth of the bacteria was observed in the main tests in all examined bacterial strains with and without metabolic activation at higher concentrations.

The mean values of revertant colonies of the negative (vehicle/solvent) control plates were within the historical control range, the reference mutagens showed the expected increase in the number of revertant colonies, the viability of the bacterial cells was checked by a plating experiment in each test. At least five analyzable concentrations were presented in all strains of the main tests, the examined concentration range was considered to be adequate. The study was considered to be valid.

The reported data of this mutagenicity assay show that under the experimental conditions applied the test item did not induce gene mutations by base pair changes or frameshifts in the genome of the strains used. In conclusion, the test item Saccharomyces cerevisiae cell wall, extracted had no mutagenic activity on the growth of the bacterial strains under the test conditions used in this study.